Sessions are scheduled in local time (CEST)

Displaying One Session

View
Frankfurt Hall Industry Satellite Symposium

Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

Date
Thu, 11.05.2023
Time
18:30 - 19:30
Room
Frankfurt Hall
Chairs
  • Diana I. Lüftner (Brandenburg an der Havel, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

Welcome and introduction (ID 960)

Lecture Time
18:30 - 18:35
Session Name
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Diana I. Lüftner (Brandenburg an der Havel, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

Are we taking the right choices? New insights on risk assessment in patients with HER2+ EBC (ID 961)

Lecture Time
18:35 - 18:45
Session Name
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Christian Jackisch (Offenbach am Main, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

The wise move: Current strategies in high-risk HER2+ EBC (ID 962)

Lecture Time
18:45 - 18:55
Session Name
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Miguel Martin Jimenez (Madrid, Spain)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

From data to practice: A clinical case challenge (ID 963)

Lecture Time
18:55 - 19:10
Session Name
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Christian Jackisch (Offenbach am Main, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

Delivering the continuum of care: Setting each patient up for treatment success (ID 964)

Lecture Time
19:10 - 19:25
Session Name
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Diana I. Lüftner (Brandenburg an der Havel, Germany)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)

Q&A and closing remarks (ID 965)

Lecture Time
19:25 - 19:30
Session Name
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer (ID 26)
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
  • Diana I. Lüftner (Brandenburg an der Havel, Germany)